Strong Results against Influenza in new SCN Study
Recent studies show that SCN’s patented and trademark protected immune stimulating product Immulina gives good protection against the influenza virus H1N1, similar to the ‘bird flu’ virus H5N1. The financial potential of this is significant, as the results may enable new virus treatments and ways to strengthen the immune system in both humans and animals.Recent results from animal studies commissioned by Scandinavian Clinical Nutrition (SCN) and carried out at the Louisiana State University in USA indicate that SCN’s immune-modulating product Immulina gives good protection against the